Beauty Farm Medical and Health Industry Inc. repurchased 39,000 ordinary shares on 04 September 2026 through on-market transactions on the Hong Kong Stock Exchange, according to the company’s Next Day Disclosure Return released on 04 September 2026.

The buyback was executed at prices ranging between HK$17.33 and HK$17.73 per share, with a volume-weighted average cost of HK$17.52. Aggregate consideration reached HK$0.68 million.

Following the transaction: • Issued shares (excluding treasury shares) fell from 247.96 million to 247.92 million, a decrease of 0.016%. • Treasury shares increased from 3.63 million to 3.67 million. • Total issued share capital remained unchanged at 251.59 million shares, as the repurchased stock was retained as treasury shares.

The repurchase forms part of the mandate approved on 26 June 2026, which authorises the company to buy back up to 24.85 million shares. Cumulative purchases under this mandate now stand at 598,500 shares, equivalent to 0.24% of the company’s issued share base at the mandate date. Under Hong Kong listing rules, Beauty Farm Medical is restricted from issuing, selling, or transferring any shares for 30 days following the 04 September transaction, imposing a moratorium until 04 October 2026.